Details for Patent: 9,050,263
✉ Email this page to a colleague
Which drugs does patent 9,050,263 protect, and when does it expire?
Patent 9,050,263 protects TALICIA and is included in one NDA.
This patent has twenty-nine patent family members in twenty-four countries.
Summary for Patent: 9,050,263
| Title: | Pharmaceutical compositions for the treatment of Helicobacter pylori |
| Abstract: | Single oral solid dosage form comprising an immediate release first dosage composition having at least two antibiotic agents and a delayed release second dosage composition having a proton pump inhibitor are provided herein. The single oral solid dosage form according to some aspects of the invention can be used for the treatment of disorders associated with infection by H. pylori or the prevention of recurrence of disorders associated with infection by H. pylori. |
| Inventor(s): | Fathi; Reza (HoHoKus, NJ), Raday; Gilead (Palo Alto, CA), Goldberg; Guy (Tel Aviv, IL), Gosselin; Patrick (Laval, CA) |
| Assignee: | RedHill Biopharma Ltd. (Tel-Aviv, IL) |
| Application Number: | 14/179,197 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Device; Dosage form; |
Drugs Protected by US Patent 9,050,263
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Redhill | TALICIA | amoxicillin; omeprazole magnesium; rifabutin | CAPSULE, DELAYED RELEASE;ORAL | 213004-001 | Nov 1, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF H. PYLORI INFECTION IN ADULTS | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,050,263
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014216373 | ⤷ Sign Up | |||
| Brazil | 112015019264 | ⤷ Sign Up | |||
| Canada | 2900763 | ⤷ Sign Up | |||
| Chile | 2015002253 | ⤷ Sign Up | |||
| China | 105163743 | ⤷ Sign Up | |||
| China | 109893516 | ⤷ Sign Up | |||
| Denmark | 2956149 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
